Article Details

Sanofi Acquires Vigil Neuroscience for $470 Million to Advance Neurodegenerative Disease ...

Retrieved on: 2025-05-26 15:06:07

Tags for this article:

Click the tags to see associated articles and topics

Sanofi Acquires Vigil Neuroscience for $470 Million to Advance Neurodegenerative Disease .... View article details on hiswai:

Excerpt

Vigil Neuroscience specializes in developing therapies targeting microglia, immune cells found in the central nervous system that play a role in ...

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo